1. Home
  2. IE vs STOK Comparison

IE vs STOK Comparison

Compare IE & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ivanhoe Electric Inc.

IE

Ivanhoe Electric Inc.

HOLD

Current Price

$12.79

Market Cap

2.1B

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$30.10

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IE
STOK
Founded
2020
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
IE
STOK
Price
$12.79
$30.10
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$18.17
$39.20
AVG Volume (30 Days)
1.8M
417.6K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.73
EPS
N/A
N/A
Revenue
$3,244,000.00
$184,420,000.00
Revenue This Year
$44.79
N/A
Revenue Next Year
$16.22
$77.49
P/E Ratio
N/A
N/A
Revenue Growth
11.82
404.50
52 Week Low
$6.53
$9.09
52 Week High
$21.55
$40.22

Technical Indicators

Market Signals
Indicator
IE
STOK
Relative Strength Index (RSI) 43.78 31.93
Support Level $12.11 $25.21
Resistance Level $13.63 $35.11
Average True Range (ATR) 0.86 1.56
MACD -0.01 -0.32
Stochastic Oscillator 17.69 6.05

Price Performance

Historical Comparison
IE
STOK

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: